The global Direct Lateral Interbody Fusion (DLIF) and eXtreme Lateral Interbody Fusion (XLIF) implants market is currently undergoing a significant transformation. Driven by a paradigm shift toward minimally invasive spine surgery (MISS), these lateral access techniques have become gold standards for treating degenerative disc diseases, scoliosis, and spondylolisthesis. By accessing...